Compound Detail
CHEMBL3039518
BATEFENTEROL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Basic Information
| ChEMBL ID | CHEMBL3039518 |
| Name | BATEFENTEROL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | URWYQGVSPQJGGB-DHUJRADRSA-N |
4
Targets
9
Activities
3
Assay Types
5
PK Parameters
20
Publications
6
Known Names
1
Indications
3
Mechanisms
Molecular Properties
740.3
MW (Da)
6.43
ALogP
9
HBA
6
HBD
165.2
PSA (Ų)
0.08
QED
3
Ro5 Violations
13
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Beta-2 adrenergic receptor agonist | AGONIST | Beta-2 adrenergic receptor | ✓ | ✓ |
| Muscarinic acetylcholine receptor M2 antagonist | ANTAGONIST | Muscarinic acetylcholine receptor M2 | ✓ | ✓ |
| Muscarinic acetylcholine receptor M3 antagonist | ANTAGONIST | Muscarinic acetylcholine receptor M3 | ✓ | ✓ |
Indications
Pulmonary Disease, Chronic Obstructive
Activity Summary
EC50 6 meas. best 9.6
IC50 2 meas. best 8.8
Ki 1 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-2 adrenergic receptor CHEMBL210 | EC50 | 9.6 | 9.0567 | 0.3 | 3 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | IC50 | 8.8 | 8.8 | 1.6 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 8.7 | 8.7 | 2.0 | 1 |
| Cavia porcellus CHEMBL369 | EC50 | 8.0 | 7.6333 | 10.0 | 3 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | IC50 | 6.01 | 6.01 | 986.7 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 75.33 | mL.min-1.kg-1 | Rattus norvegicus |
| F | 0.45 | % | Rattus norvegicus |
| T1/2 | 0.1883 | hr | Homo sapiens |
| T1/2 | 0.18 | hr | Rattus norvegicus |
| T1/2 | 0.05 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5724801 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5724801 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5058577 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5058577 | U2OS | 304 |
| - | 10.6019/CHEMBL5724801 | U2OS | 304 |
| - | 10.6019/CHEMBL5058577 | Fibroblast | 304 |
| 25629394 | 10.1021/jm501915g | Cavia porcellus | 11 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 8 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 8 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 8 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 8 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 8 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 6 |
Data from ChEMBL 36 via Core Engine